KemPharm, Inc. (KMPH)

NASDAQ: KMPH · IEX Real-Time Price · USD
6.11
-0.07 (-1.13%)
Aug 12, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016201520142013
Revenue
28.6513.2912.84000000
Revenue Growth (YoY)
115.61%3.50%-------
Gross Profit
28.6513.2912.84000000
Selling, General & Admin
8.77.9210.8212.5112.77148.884.531.35
Research & Development
10.168.8419.4241.7620.5920.4713.9311.923.37
Other Operating Expenses
2.062.132.951.6403.01000
Operating Expenses
20.9218.933.1855.933.3737.4822.8116.444.72
Operating Income
7.73-5.61-20.34-55.9-33.37-37.48-22.81-16.44-4.72
Interest Expense / Income
0.234.794.865.475.785.512.671.610.16
Other Expense / Income
16.022.4-0.65-4.784.29-26.4629.156.430.37
Pretax Income
-8.52-12.79-24.54-56.59-43.43-16.53-54.64-24.48-5.25
Income Tax
0.03-0.03-0.02-0.13-0.04-0.020.03-0.02-0.02
Net Income
-8.56-12.76-24.52-56.47-43.39-16.52-54.66-24.46-5.23
Preferred Dividends
54.3400000000
Net Income Common
-62.9-12.76-24.52-56.47-43.39-16.52-54.66-24.46-5.23
Shares Outstanding (Basic)
3042111000
Shares Outstanding (Diluted)
3042111000
Shares Change
647.72%114.79%65.39%22.36%0.38%98.10%209.47%--
EPS (Basic)
-2.11-3.21-13.23-50.39-47.36-18.08-118.72-164.32-35.20
EPS (Diluted)
-2.11-3.21-13.23-50.39-47.36-18.08-118.72-164.32-35.20
Free Cash Flow Per Share
0.35-0.49-12.82-48.39-36.34-33.34-44.30-98.90-29.30
Gross Margin
100.00%100.00%100.00%------
Operating Margin
27.00%-42.20%-158.40%------
Profit Margin
-219.50%-96.00%-191.00%------
Free Cash Flow Margin
36.10%-14.80%-185.10%------
Effective Tax Rate
-0.40%0.27%0.09%0.22%0.10%0.09%-0.05%0.09%0.38%
EBITDA
-8.04-7.74-19.38-50.8-37.32-10.85-51.88-22.8-5.02
EBITDA Margin
-28.10%-58.20%-151.00%------
Depreciation & Amortization
0.260.270.30.320.340.180.080.080.07
EBIT
-8.3-8.01-19.69-51.12-37.65-11.02-51.97-22.87-5.09
EBIT Margin
-29.00%-60.30%-153.30%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).